Original Source(s)
Related Content
Tenecteplase Fails to Boost EVT Outcomes
Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.
May 14, 2026
-
6 min
Nodular Fasciitis May Mimic Sarcoma
Molecular testing may help avoid overtreatment when benign soft-tissue tumors present with atypical clinical or histologic features.
May 11, 2026
-
4 min
FDA Expands Guselkumab Label in PsA
Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.
May 29, 2026
-
2 min